Current stage-Stage III-III-B - Page 2 of 2 Posts on Medivizor
Navigation Menu

Current stage-Stage III-III-B Posts on Medivizor

Adding bevacizumab to letrozole treatment in hormone receptor-positive metastatic breast cancer – A good idea?

Adding bevacizumab to letrozole treatment in hormone receptor-positive metastatic breast cancer – A good idea?

Posted by on Jul 18, 2016 in Breast cancer | 0 comments

In a nutshell This study looked at the effect of adding bevacizumab (Avastin) to letrozole (Femara) treatment in patients with hormone receptor-positive (HR+) metastatic (spread to other areas) breast cancer. They found that bevacizumab treatment prolonged the amount of time before patients experienced worsening of their...

Read More

Immunotherapy drug for treating advanced NSCLC

Posted by on Mar 20, 2016 in Lung cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of nivolumab (Opdivo) and docetaxel (Taxotere) for the treatment of advanced squamous-cell non-small-cell lung cancer (NSCLC). The study concluded that nivolumab is more effective and safer than docetaxel for this type of cancer. Some background PD-L1 is a protein that...

Read More

The potential of Nivolumab in treating advanced NSCLC

The potential of Nivolumab in treating advanced NSCLC

Posted by on Jan 25, 2016 in Lung cancer | 0 comments

In a nutshell This study compared the efficacy of antitumor drugs nivolumab (Opdivo) and docetaxel (Taxotere) in the treatment of advanced non-small-cell lung cancer (NSCLC). The study concluded that nivolumab has better activity in advanced nonsquamous NSCLC which express the ligand PD-L1 and has a safer toxicity profile overall than docetaxel. Some...

Read More

Can a combination of targeted treatments work better than one in non-small cell lung cancer?

Can a combination of targeted treatments work better than one in non-small cell lung cancer?

Posted by on Oct 10, 2015 in Lung cancer | 0 comments

In a nutshell This study investigated the effect of erlotinib (Tarceva) with high dose celecoxib (Celebrex) in patients with advanced non-small cell lung cancer. Some background Some non-small cell lung cancers develop and grow due to a mutation (abnormality) in the epidermal growth factor receptor (EGFR) gene. EGFR tyrosine kinase inhibitors...

Read More

Can a blood test help determine non-small-cell lung cancer patients treatment options and outcomes?

Can a blood test help determine non-small-cell lung cancer patients treatment options and outcomes?

Posted by on Jun 25, 2015 in Lung cancer | 0 comments

In a nutshell This study examined the effectiveness of a blood test (commercially known as VeriStrat) used for predicting the benefit of EGFR inhibitors in non-small cell lung cancer. Some background The epidermal growth factor receptor (EGFR) is involved in cell growth. Increased levels of EGFR can increase non-small cell lung...

Read More

Linifanib with carboplatin and paclitaxel in nonsquamous non-small cell lung cancer

Posted by on May 11, 2015 in Lung cancer | 0 comments

In a nutshell The objective of this study was to determine whether addition of  linifanib to a combination of carboplatin (Paraplatin) and paclitaxel (Taxol) could benefit advanced nonsquamous non-small cell lung cancer (NSCLC) patients. Some background Nonsquamous NSCLC is a type of lung cancer where the cancer starts in cells other than...

Read More

Can peritoneal spread be prevented in high risk colon cancer patients?

Can peritoneal spread be prevented in high risk colon cancer patients?

Posted by on Mar 30, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared two treatment approaches on the long-term outcomes of colon cancer patients at risk of peritoneal metastases (spread of the cancer to the lining of the abdomen). Some background The spread of colon cancer to the peritoneum is a life-threatening condition. One treatment is cytoreductive surgery with hyperthermic...

Read More

Maintenance therapy does not impair subsequent treatment with pemetrexed in metastatic lung cancer

Posted by on Feb 23, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to determine whether previous maintenance therapy with gemcitabine or erlotinib impaired pemetrexed treatment.  Some background Maintenance therapy is the ongoing use of chemotherapy  or another treatment given to help the primary treatment succeed and prevent cancer recurrence. Two drugs have been...

Read More

Treating recurrent rectal caner that invades the pelvic area: major surgical options

Posted by on Mar 13, 2013 in Colorectal cancer | 0 comments

In a nutshell This article reviewed several clinical studies where radical surgical procedures have been used to treat rectal cancer that has invaded the area of the pelvis.  Some background The sacrum bone is the lowest part of the spine which sits between the hip bones.  It is made up of 5 vertebrae which are separate bones during...

Read More